Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
2.320
+0.020 (0.87%)
At close: Oct 2, 2026, 4:00 PM EDT
2.336
+0.016 (0.69%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Fate Therapeutics Market Cap
Fate Therapeutics has a market cap or net worth of $277.98 million as of October 2, 2026. Its market cap has increased by 92.78% in one year.
Market Cap
277.98M
Enterprise Value
199.89M
1-Year Change
92.78%
Ranking
Category
Stock Price
$2.32
ChartMarket Cap Chart
Since October 1, 2013, Fate Therapeutics's market cap has increased from $126.10M to $277.98M, an increase of 120.45%. That is a compound annual growth rate of 6.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 277.98M | 145.14% |
| Dec 31, 2025 | 113.40M | -39.65% |
| Dec 31, 2024 | 187.90M | -49.05% |
| Dec 29, 2023 | 368.80M | -62.38% |
| Dec 30, 2022 | 980.40M | -82.45% |
| Dec 31, 2021 | 5.59B | -29.57% |
| Dec 31, 2020 | 7.93B | 436.27% |
| Dec 31, 2019 | 1.48B | 78.70% |
| Dec 31, 2018 | 827.80M | 225.01% |
| Dec 29, 2017 | 254.70M | 197.20% |
| Dec 30, 2016 | 85.70M | -11.47% |
| Dec 31, 2015 | 96.80M | -6.47% |
| Dec 31, 2014 | 103.50M | -19.01% |
| Dec 31, 2013 | 127.80M | 1.35% |
| Oct 1, 2013 | 126.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 286.49M |
| Rocket Pharmaceuticals | 284.32M |
| Clinuvel Pharmaceuticals | 282.75M |
| Indaptus Therapeutics | 282.47M |
| Fulcrum Therapeutics | 280.77M |
| X4 Pharmaceuticals | 280.59M |
| AC Immune | 279.39M |
| EyePoint | 278.47M |